Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

7-Time 212 Mr. Olympia Champion James “Flex” Lewis Forced to Withdraw from 2020 Mr. Olympia


To his own disappointment and that of his countless fans around the world, IFBB Pro League athlete and 212 Mr. Olympia GOAT Flex Lewis announced Friday that he will not compete in the 2020 Mr. Olympia. The decision was made in conjunction with Flex’s team of sports medicine doctors, who deemed his shoulder injury too deleterious to compete. Perpetual front runner that he is, Flex by his own admission agonized over the dilemma.

“Since doing my first show at 19 years old, bodybuilding has been my life,” said Flex. “So making this decision with my team was not easy. I fought it hard, and still struggle with it, but I am now mentally focused on the rehab process. Every bodybuilder’s dream is to become Mr. Olympia; I have achieved this feat in the 212 class not just once but seven times over. After stepping away from the 212 class, the goal shifted to becoming the first ever two-division “Champ Champ” – a feat never achieved in this sport. I truly believe I was on course to showcase something special. Unfortunately, it will not happen this year.”

Mr. Olympia, dubbed the “Super Bowl of bodybuilding,” is typically held each September in Las Vegas. Per COVID, this year’s competition was rescheduled to December. Flex Lewis has been competing actively since 2008, winning the 212-pound division an unprecedented 7 consecutive times. In 2018, Flex retired from the 212 Olympia division and announced that he would be taking on all comers in 2020’s Open Class. Those plans now derailed, Flex moves forward with the Miami Orthopedic & Sports Medicine team in his corner. They’re game planning an aggressive rehabilitation program along with stem cell treatment from BioXcellerator.

Lewis continued, “The decision not to compete was made easier when my medical team stressed that if I continued to train I could do even more damage, which could have threatened or possibly ended my career. Pushing through pain is something athletes are accustomed to; I have hidden a lot of injuries throughout the years, as I had to this point. But I have to come to terms with reality. Now my entire focus is on my health and rehabbing my injuries to return a bigger, better bodybuilder than ever before.”

This tempestuous news comes with it a silver lining: Expect to hear from Flex in the coming weeks as he documents his road to recovery. You’ll follow Flex from the therapy table all the way to the 2021 Mr. Olympia stage as he strives to do the unthinkable—become the first ever two-division champion in both the 212 lbs. and Open Class ranks. We wish Flex a speedy recovery and look forward to the show -the gun show- in 2021.

Share article on social media or email:



Cancer Support Community CNJ Honors Jason P. Schaible Memorial Fund and Merck & Co., Inc. at Socially Distant Event


Guests arriving at Inspiring Hope Under the Stars

“CSCCNJ is a community of hope. And while being virtually connected is essential during these times, we felt it was important to be physically together this evening—even if it is a bit different than usual” Amy Sutton, CEO of CSCCNJ.

Cancer Support Community Central NJ (CSCCNJ), like most organizations, has been forced to face head-on the challenges created for non-profits by the COVID-19 health crisis. But the fear, stress, and anxiety that many feel during these uncertain times are what people with cancer and their loved ones experience all the time when faced with a cancer diagnosis. With a 51% increase in average program attendance in the first month of stay-at-home orders, CSCCNJ knows that that now, more than ever, their social and emotional support services are vital to the wellbeing of the community.

To raise the funds necessary to keep its vital programs available virtually, the committee planning CSCCNJ’s largest fundraiser of the year, Inspiring Hope, understood the importance of creating a successful experience for their benefactors. Knowing that traditional events held in ballrooms or banquet halls were not an option, and fearing there would be “Zoom fatigue,” the Inspiring Hope Committee used their creativity and grit to create an opportunity for people to physically come together and celebrate community in a safe, socially-distanced way.

On September 24, Inspiring Hope became Inspiring Hope Under the Stars, held on a fairway at Fiddler’s Elbow Country Club, with guests in golf carts outfitted with boxed appetizers, entrees (a choice of lobster roll or sliced filet mignon sandwich) and dessert; beverages; and a goodie bag with hand sanitizers, face masks, glow sticks, and mosquito repellant wipes. From their golf cart, guests were treated to live music and a mission-focused program broadcast on a 40 ft. movie screen.

Inspiring Hope Under the Stars was unlike previous years—and guests were able to dress more casually than a traditional dinner event—but the focus on mission and celebrating the honorees of the Nancy and Marty Dowd Spirit of Hope Award was unchanged. “CSCCNJ is a community of hope. And while being virtually connected is essential during these times, we felt it was important to be physically together this evening—even if it is a bit different than usual—to honor two of our valued partners, the Jason P. Schaible Memorial Fund and Merck & Co. Inc.; who are making a tremendous impact, not only on our work, but on the lives of so many people affected by cancer in the community,” said Amy Sutton, CEO of CSCCNJ.

The event raised over $130,000 to enable CSCCNJ to continue providing emotional and social support services at no charge to people with cancer, survivors, loved ones, caregivers, and bereaved.

The Jason P. Schaible Memorial Fund is an organization rooted in community and created in memory of Jason Schaible, who lost his battle with Hodgkin’s Lymphoma on August 11, 2007. Throughout his lengthy battle with cancer, Jason never lost sight of the importance of friends, family, and the community. His message to all those who knew him was to always strive to be the best they can be by “Raising the Bar” every day. In partnership with the fund, CSCCNJ has provided non-medical financial, social, and emotional support to families impacted by a pediatric cancer diagnosis. One family who benefited from this partnership shared their cancer journey and presented the award to the fund’s founders, Dr. Vincent and Mrs. Karen Schaible.

Merck & Co., Inc. has been a crucial partner in CSCCNJ’s Multicultural Outreach Initiative, which is grounded in cultural humility, to educate and empower vulnerable populations before and during a cancer experience, allowing them to live fully through and beyond the diagnosis. During the pandemic lockdown, outreach to vulnerable populations has grown by 70% thanks in large part to the tireless work Hiral Shukla, a recently hired Public Health Coordinator, and the critical relationships with community organizations that she has developed. Thanks in part to Merck & Co.’s generosity, Shukla was added to the team.

Inspiring Hope Under the Stars was supported by Ambassador Sponsors: BD, JLL, and Merck; and Benefactor Sponsors: Carecycle, East West Connection, Eli Lilly and Company, Novartis Pharmaceuticals Corp, PwC, Regional Cancer Care Associates Central New Jersey, RWJBarnabas Health, Sanofi US, Schaible Russo Financial, Schaible’s Plumbing and Heating, Inc, and Taiho Oncology.

About Cancer Support Community Central New Jersey:

Cancer Support Community Central New Jersey (CSCCNJ) is a registered 501(c)(3). As experts in oncology mental health, the organization provides support, education, and hope to all people with cancer and their loved ones. Backed by evidence that the best cancer care includes social and emotional support, CSCCNJ creates a caring community to help individuals live with, through and beyond cancer. At no charge to people with cancer, family members, and caregivers, the organization delivers essential programs and services including individual and group support; educational, nutrition, and healthy-cooking workshops; classes to enhance health and wellness; and activities that build social connections. CSCCNJ has temporarily moved its program of support to a virtual platform since the start of stay-at-home orders, and will continue to provide both virtual and in-person support in the future. For more information, visit their website at cancersupportcnj.org or call (908) 658-5400.

Share article on social media or email:

FPP and Standard Sign Licensing and Supply Agreement


Florida Pharmaceutical Products, LLC (FPP) a pharmaceutical company involved in the Development, Sales, Marketing and Distribution of Generic Pharmaceuticals and Standard Chem. & Pharm. Co., Ltd (Standard) a company involved in the Development, Manufacturing, Distribution, and Licensing of pharmaceuticals are pleased to announce the signing of an agreement for the Licensing, Supply and Distribution of an approved ANDA for Riluzole Tablets developed by Standard, approved by the FDA, and scheduled to launch in November.

The product has sales of approximately $5 million according to IQVIA™. The ANDA product will be sold and distributed by FPP, in the Quinn Label, within the US. “We are pleased to be working with Standard on this project and look forward to a successful launch,” said Larry J. Lapila, President of FPP. The ANDA will be manufactured by Standard. “We are pleased to partner with FPP to launch Riluzole Tablets in the US market and support our shared commitment for reliable and affordable medicines for the benefit of patients,” said Standard.

About Florida Pharmaceutical:

Florida Pharmaceutical Products, LLC (FPP) is a Boca Raton based pharmaceutical company involved in the development of Generic Pharmaceuticals seeking to gain approval and/or license of niche generic products in a broad range of therapeutic areas for marketing and distribution in the US.

About Standard:

Standard Chem. & Pharm. Co., Ltd (Standard) is one of the leading pharmaceutical companies in Taiwan. Standard is founded in 1967, and has been a publicly held company since 1995. A vertically integrated pharma with manufacturing capability in API and FDF products. Standard is committed to supplying reliable and high-quality drug products. Standard has been inspected by US-FDA since 2000, and supplying pharmaceutical products in the US for years.

Share article on social media or email:

Lumeda Announces Appointment of Alexander Zinke as Chief Executive Officer


News Image

Lumeda Inc., a biophotonics systems company advancing photodynamic therapy (PDT) for treating cancer, today announced the appointment of Alexander (Sandy) Zinke as Chief Executive Officer. Mr. Zinke will also join the company board of directors.

As Lumeda’s chief executive, Mr. Zinke will refine and implement the company strategic plan leading to commercial introduction of its DigiLum™ photodynamic therapy (PDT) product as an adjuvant treatment following lung cancer tumor resection.

“We are pleased to have a seasoned healthcare industry executive leading Lumeda into its next phase,” said Trevor MacDougall and Paul Sanders, the company founders. “Sandy’s vision for and expertise in launching new medical technologies will bring this important lung cancer therapy to the market. He brings significant experience and a network of industry contacts that will help Lumeda develop the key relationships with medical thought leaders and commercial partners critically needed to accelerate the introduction of this novel technology to the clinic, where it promises to reduce the risk of recurrence and improve patient outcomes.”

Mr. Zinke has over 20 years of global healthcare industry experience with innovative companies including Boston Scientific, Cynosure/Hologic and CDx Diagnostics. Most recently, he was Vice President of Marketing & Business Development with CDx Diagnostics, known for an advanced diagnostic platform used to preempt cancer based on AI-enabled tissue analysis and 3D imaging. Over the last 10 years he has led teams that have developed and commercialized more than a dozen products and programs.

“I am excited and honored to be joining the Lumeda team comprised of experienced engineers and entrepreneurs with a track record of developing practical solutions to technical challenges across several industries,” said Zinke.

Mr. Zinke’s arrival augments the Lumeda management team with medical product commercialization and industry experience that complements the team’s strengths in engineering, operations and business development.

About Lumeda:

Lumeda is advancing PDT to treat NSCLC and other thoracic malignancies. The company applies advanced photonics and proprietary software to automate and digitize PDT light delivery to improve PDT efficacy, ease of use and treatment planning. The multidisciplinary Lumeda team has decades of experience in the photonics industry, with expertise in systems engineering and commercialization of new technology. Lumeda is committed to pioneering the advancement and utility of PDT for improved patient outcomes. For more information, please visit lumedainc.com.

Share article on social media or email:

What Is It? How Can We Improve It?, Upcoming Webinar Hosted by Xtalks


Important outcome measures for IBD include rates of unplanned care, hospitalization, corticosteroid and narcotic use, health-related quality of life and symptoms.

Variation in adherence to management guidelines for inflammatory bowel disease (IBD) suggests variable quality of care. Furthermore, evidence suggests variation in patient outcomes by geography, race, type and experience of provider.

Quality indicators (QIs) have been developed to measure the structure, processes and outcomes of health care delivery, and can be used to measure improvement over time. In IBD, several societies and groups have publicized quality indicators. Important outcome measures for IBD include rates of unplanned care, hospitalization, corticosteroid and narcotic use, health-related quality of life and symptoms.

Traditional methods for quality improvement can and have been applied to IBD. Efforts to improve care require sustained, iterative changes over time. Several examples exist of single-center efforts to improve processes of care. A quality improvement network has used the Model for Improvement to demonstrate improvement in patient outcomes over time including unplanned care and other outcomes. A pediatric improvement network has demonstrated improved remission rates over time. Quality of care for IBD can be measured and improved.

Join Gil Y. Melmed, MD, Co-Director, IBD Center, Professor of Medicine, Cedars-Sinai Medical Center and Kenneth W Gaither, PhD, Vice President, Medical Imaging, Bioclinica in a live webinar on Wednesday, October 28, 2020 at 11am EDT (4pm BST/UK).

For more information or to register for this event, visit Quality Of Care In IBD: What Is It? How Can We Improve It?

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Health Care M&A Volume Leveled Out in Q3:2020, According to HealthCareMandA.com


News Image

“Seeing deal volume pick up again in sectors such as Home Health & Hospice, eHealth and Other Services shows there’s still strong interest in the market. “

Health care merger and acquisition activity remained steady in the third quarter of 2020, with 346 announced transactions, compared with the previous quarter’s 341 announced deals. M&A in the third quarter of 2020 was 25% lower than the same quarter in 2019, however.

The services sectors saw an uptick in deal volume, rising 8% to 231 deals compared with the second quarter. Deal activity in several sectors, such as Behavioral HealthCare, Physician Medical Groups and Laboratories, MRI & Dialysis all jumped by double digits compared with the previous quarter. Home Health & Hospice saw a triple-digit increase, up 120% to 22 deals. Hospital transactions declined, dropping 55% compared with Q2:20.

Activity in the technology sectors declined by 10% in the third quarter compared with the previous quarter. The only sector that saw an increase in deal activity was the eHealth sector, rising 14% to 58 deals.

Spending on all healthcare deals skyrocketed in the third quarter, up 765% compared with the second quarter and 113% compared with the same quarter in 2019. Combined spending reached $110.8 billion. The year’s largest deals, including Gilead Sciences, Inc.’s acquisition of Immunomedics for $21 billion, and the $18.5 billion merger of Teladoc Health and Livongo Health, Inc., were all announced in the third quarter.

“The third quarter is usually a quiet time in the healthcare deal making cycle, but with the coronavirus pandemic, it was difficult to anticipate results,” said Lisa E. Phillips, editor of HealthCareMandA.com. “Seeing deal volume pick up again in sectors such as Home Health & Hospice, eHealth and Other Services shows there’s still strong interest in the market.

“The third quarter in 2020 had a hard comparison against the very strong results from the third quarter in 2019, even without Covid-19,” Phillips added. “The fourth quarter has already started off strong for sectors that didn’t fare as well. We expect to see the usual year-end momentum return.”

For more information on the HealthCareMandA.com investment research source, or for a membership in any of Irving Levin Associates’ services, please call 800-248-1668. Irving Levin Associates, Inc., established in 1948, is headquartered in Norwalk, Connecticut and is online at http://www.levinassociates.com. This privately held corporation publishes annual and quarterly research reports, monthly and weekly newsletters, and maintains merger and acquisition databases on the health care and senior housing markets. If you would like to receive future releases, please email pressreleases@levinassociates.com.

Share article on social media or email:

Strategies for Differentiated Oral Drugs, Upcoming Webinar Hosted by Xtalks


This webinar will discuss some key challenges of oral drug formulations, including the swallowability of tablets, bitter taste and the inconvenience of multiple doses.

While advancements in drug delivery are continually improving drug efficacy and bioavailability, there is still a significant unmet need in terms of developing formulations that make patients’ lives easier. Patient-centricity is not only about best supporting the end user – it’s also about differentiating your product in a sea of oral drug formulations, particularly when looking to file a generic or 505(b)(2) application.

This webinar will discuss some key challenges of oral drug formulations, including the swallowability of tablets, bitter taste and the inconvenience of multiple doses. The team at Lubrizol Life Science Health (LLS Health) will then uncover strategies for overcoming these challenges which will also help differentiate your product, such as with extended drug release, taste masking and tablet size reduction.

Join Gaurab Sengupta, Global Business Manager – Pharmaceutical Excipients, LLS Health and Rajib Bhattacharjee, Global Market Manager – Oral Treatments, LLS Health in a live webinar on Thursday, October 29, 2020 at 9am EDT (1pm GMT/UK).

For more information or to register for this event, visit Patient-Centric Formulations: Strategies for Differentiated Oral Drugs.

About The Lubrizol Corporation

The Lubrizol Corporation, a Berkshire Hathaway Company, leverages its unmatched science to unlock immense possibilities at the molecular level, driving sustainable and measurable results to help the world Move Cleaner, Create Smarter and Live Better. Founded in 1928, Lubrizol owns and operates more than 100 manufacturing facilities, sales and technical offices around the world and has approximately 8,800 employees. For more information, visit http://www.Lubrizol.com.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Join ABQAURP Now as a Professional Member – New Complimentary Courses Just Released


News Image

“Never Stop your Quest for Excellence”

Professional Membership with the AMERICAN BOARD OF QUALITY ASSURANCE AND UTILIZATION REVIEW PHYSICIANS® (ABQAURP) was established for health care professionals who are devoted to the concepts and objectives outlined in ABQAURP’s Mission Statement. Many choose to utilize this membership as a pathway to HCQM Certification, taking advantage of educational opportunities while preparing for the certification exam.

Professional Membership with ABQAURP strengthens your pursuit of excellence in health care quality management and patient safety! ABQAURP’s education, live conferences, networking, Career Center, and Health Care Quality and Management (HCQM) Certification provide the foundation and continuing education to stay on top of today’s ever-changing health care landscape.

Benefits include discounted registration fees for the Certification Exam, live conferences, and all ACCME-accredited online continuing medical education courses. The education credits earned for these programs may be applied toward eligibility for the certification exam. Professional members are also listed in ABQAURP’s online directory and have unlimited access to the Member’s only section of the website. Professional members can take advantage of employment opportunities through ABQAURP’s participating health care placement companies and prospective networking at continuing education conferences.

CME / CE Spotlight Benefit

As an additional benefit, Professional Members now have access to ABQAURP’s CME/CE Spotlight which offers health care quality and management online courses from our course catalog for free!

The latest spotlight course was just released: Intro to Digital Health

Digital Health, also known as telemedicine, has evolved over the last forty years. The 2020 COVID-19 pandemic has thrust many health care providers into this technology without fully understanding the different terminology and its place in today’s medicine. The Intro to Digital Health multimedia online course is provided in two parts: it begins with a thirty-minute video and continues on with PDF reading materials. The course seeks to clarify digital health terminology, initiatives, and outlines how health care professionals can incorporate various aspects of this technology into daily practice.

At the conclusion of this activity, attendees should be able to:

  • Describe the eight primary Digital Health modalities and the associated technology
  • Recognize how the Activated patient achieves better outcomes at less cost
  • Evaluate how barriers to Digital Health implementation can be quickly resolved
  • Demonstrate ways to incorporate Digital Health components into their practice to safely engage and monitor patients while improving productivity

The CME/CE Spotlight course, Intro to Digital Health, is also available to non-ABQAURP members for a very limited time. Use promo code: NMFREECE through October 26th to register online at: https://education.abqaurp.org/topclass/topclass.do?expand-OfferingDetails-Offeringid=196955.

In addition to the spotlight courses, Professional Members can now find these courses free on our the ABQAURP website any time. View the course catalog at: https://education.abqaurp.org/topclass/searchCatalog.do?catId=0 to order.

Insurance Denials: Appeals, Prevention, and Contracting Advice

NTOCC Webinar – Shared Decision Making

NTOCC Webinar – Improving Transitions for Heart Failure Patients

NTOCC Webinar – Coming of Age: Social Determinants Matter

NTOCC Webinar – Improving Healthcare Coordination through Technology

NTOCC Webinar – Aging Life Care Support

NTOCC Webinar – Integrated Population Health Strategy

NTOCC Webinar – Mastery of the Social Determinants of Health

Visit the ABQAURP website at: https://www.abqaurp.org/ABQMain/Membership/Professional_Membership/ABQMain/Professional_Membership.aspx or call (800) 998-6030 to join as a Professional Member today!

About ABQAURP

Celebrating over 40 years of excellence in Health Care Quality Management and Patient Safety, ABQAURP is a premier professional association providing Health Care Quality and Management (HCQM) certification, ACCME-accredited continuing medical education, and membership to health care professionals worldwide. Learn more at: http://www.abqaurp.org.

Share article on social media or email:

American Council of Learned Societies Fellowships Offer Opportunities for Scholars to Contribute to Social Justice Initiatives and Increase Civic Understanding


ACLS Fellowship Competitions

Learn more about ACLS fellowship opportunities for early career and senior humanities and social sciences PhDs at www.acls.org

The American Council of Learned Societies (ACLS), which stewards $25 million in fellowships and grants supporting excellence in humanistic scholarship each year, offers a variety of opportunities for both emerging and senior scholars to utilize their knowledge, training, and teaching experience in exciting and innovative new ways.

Upholding a core belief that knowledge is a public good, ACLS hosts a variety of fellowship competitions designed to allow humanities PhDs to apply their analytical, communications, and problem solving capcities to the most pressing issues facing our communities – from the continuing struggle to cope with the COVID-19 pandemic, to the roles religion plays in public life, to ever-evolving conversations about immigration, economic disparity, race, and more.

ACLS fellowships are also serving as a lifeline for early career and non-tenured academics currently facing the most challenging academic job market in a generation, providing much needed support systems and community that allow them to continue persuing knowledge during difficult social and economic times. Awards range from $55,000-$75,000 each for 12-month fellowships.


  • The ACLS Leading Edge Fellowship Program, made possible by the Henry Luce Foundation, currently offers recent PhDs in religion, theology, ethics, and related humanities fields one-year posts with nonprofit organizations to pursue publicly engaged projects documenting the impact of COVID-19 on communities and to advance collective understanding of the conditions that helped worsen that impact, such as inequality, increasing precarity, divisive media, and racism. Partners include the Smithsonian National Museum of American History (Washington, DC), Southern Poverty Law Center (Montgomery, AL), Freedom for Immigrants (Oakland, CA), and the American Friends Service Committee (Newark, NJ). Deadline for applications is Monday, November 2, 2020, 9 pm ET. Learn more about the program and qualifications here.
  • The Luce/ACLS Program in Religion, Journalism & International Affairs Fellowships, also made possible by the Luce Foundation, is an innovative program connecting scholars in the humanities and social sciences with journalists and media outlets. Their projects aim to deepen public understanding of the roles religion plays in the most pressing issues faced by societies around the world, from migration and immigration, to politics and economic policy, the environment, gender and sexuality, health and medicine, media and entertainment, and more. Deadline for applications is Wednesday, October 28, 2020, 9 pm ET. Learn more about the program and qualifications here.
  • The Mellon/ACLS Scholars and Society Fellowships, made possible by The Andrew W. Mellon Foundation, offers opportunities for faculty in PhD-granting humanities departments or programs to engage significant societal questions in their research – on cultural identity, the environment, gender, government, and more – while in residence at locally-based cultural, media, government, policy, and community organizations. Scholars are then encouraged to apply the lessons learned in these experiences toward developing innovative approaches in their classrooms on campus. Deadline for applications is Wednesday, October 28, 2020, 9 pm ET. Learn more about the program and qualifications here.

ACLS welcomes applications from PhDs representing the rich diversity of backgrounds, experiences, perspectives, and academic interests that refelct the world in which we live.

Learn more about all current ACLS fellowship opportunities and how to apply here.

Formed in 1919, the American Council of Learned Societies (ACLS) is a nonprofit federation of 75 scholarly organizations. As the preeminent representative of American scholarship in the humanities and related social sciences, ACLS holds a core belief that knowledge is a public good. As such, ACLS strives to promote the circulation of humanistic knowledge throughout society. In addition to stewarding and representing its member organizations, ACLS employs its $140 million endowment and $35 million annual operating budget to support scholarship in the humanities and social sciences and to advocate for the centrality of the humanities in the modern world.

Share article on social media or email:

AxisCare Named 2020 Healthcare Company of the Year in the Home Care Software Category by Healthcare Insights


AxisCare Named 2020 Healthcare Company of the Year in the Home Care Software Category by Healthcare Insights

“The home care market plays a massive role in the care continuum, and AxisCare’s feature-rich and user-friendly software is allowing agencies to focus on providing that care,” said Todd Allen, AxisCare’s CEO

AxisCare Home Care Software has announced that they have been named 2020 Healthcare Company of the Year in the Home Care Software category by Healthcare Insights, a leading comprehensive healthcare guide. AxisCare was chosen for the award based on its services to the industry and capabilities to endure these unforeseen times, in addition to being the fastest-growing and most efficient software platform in the home care industry.

AxisCare is a web-based software platform for the non-medical home care space, used for back-office and point-of-care documentation. At the core of the software is scheduling, which provides agencies with intuitive tools for various tasks such as creating ongoing client schedules, quickly filling open shifts, sending mass communications to clients and caregivers, real-time caregiver matching for clients in need of care, and more.

“The home care market plays a massive role in the care continuum, reducing hospital readmission rates and helping seniors remain healthy in their homes versus a facility, and AxisCare’s feature-rich and user-friendly software is allowing agencies to focus on providing that care,” said Todd Allen, AxisCare’s CEO. “We are honored to be named 2020 Healthcare Company of the Year in the Home Care category and look forward to helping more agencies streamline their back office and point of care.”

In addition to scheduling, AxisCare provides agencies with solutions for marketing and CRM, billing, payroll, compliance, state forms, HR, reporting and analytics, EVV, and a point-of-care GPS mobile app for caregivers that captures everything from signatures to COVID symptoms. Over the last few years, AxisCare has seen a massive increase in demand because of the customizability of the platform which can be molded around company-specific business models and processes.

The pioneering company also has several integrations with other vendors in the home care space, allowing its customers to easily manage processes such as background checks, automatic billing and collections, payroll, Medicaid and other payer billing, GPS caregiver tracking, and more.

About AxisCare

AxisCare’s agency management software is a back-office and point of care solution for non-medical agencies in all 50 states and 6 countries. Specializing in Private Pay, Medicaid and other 3rd-party payers, AxisCare’s platform helps agencies, from startup to franchise, stay compliant, cash-flow healthy, and ahead of their competition with built-in marketing and CRM tools, user-friendly scheduling, industry-leading business intelligence, automatic payments, and more. Recently given the industry’s top award for ease of use, overall performance and customer service, AxisCare’s mission is to transform home operations, empowering agencies to provide better care. For more information about AxisCare, please visit axiscare.com or email sales@axiscare.com.

About Healthcare Insights

The Healthcare Insights is a comprehensive guide to all things related to healthcare specializing in producing quality content for our readers on both digital and publication platforms. Their mission is to increase awareness about healthcare, helping professionals involved in the medical industry remain informed about the latest developments in the healthcare market. Their panel of experts work to collect only the most accurate and impactful information. Learn more about Healthcare Insights at thehealthcareinsights.com.

Share article on social media or email: